Taylor DL - Search Results

1

In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.

Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ. Clayman GL, et al. Among authors: taylor dl. Cancer Res. 1995 Jan 1;55(1):1-6. Cancer Res. 1995. PMID: 7805018

2

Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.

Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL. Liu TJ, et al. Among authors: taylor dl. Cancer Res. 1995 Jul 15;55(14):3117-22. Cancer Res. 1995. PMID: 7606733

3

Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation.

Janot F, el-Naggar AK, Morrison RS, Liu TJ, Taylor DL, Clayman GL. Janot F, et al. Among authors: taylor dl. Int J Cancer. 1995 Apr 21;64(2):117-23. doi: 10.1002/ijc.2910640208. Int J Cancer. 1995. PMID: 7615354

4

Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.

Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL. Liu TJ, et al. Among authors: taylor dl. Cancer Res. 1994 Jul 15;54(14):3662-7. Cancer Res. 1994. PMID: 8033080

5

Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.

Overholt SM, Liu TJ, Taylor DL, Wang M, El-Naggar AK, Shillitoe E, Adler-Storthz K, John LS, Zhang WW, Roth JA, Clayman GL. Overholt SM, et al. Among authors: taylor dl. Clin Cancer Res. 1997 Feb;3(2):185-91. Clin Cancer Res. 1997. PMID: 9815671 Clinical Trial.

6

The in vivo biologic effect of interleukin 2 and interferon alfa on natural immunity in patients with head and neck cancer.

Schantz SP, Clayman G, Racz T, Grimm EA, Liu FJ, Lavedan P, Taylor D, Pellegrino C, Savage H. Schantz SP, et al. Arch Otolaryngol Head Neck Surg. 1990 Nov;116(11):1302-8. doi: 10.1001/archotol.1990.01870110074009. Arch Otolaryngol Head Neck Surg. 1990. PMID: 2242261

7

Acute-phase proteins in patients with head and neck cancer treated with interleukin 2/interferon alfa.

Clayman GL, Liu FJ, Savage HE, Taylor DL, Lavedan P, Buchsbaum RM, Pellegrino C, Trujillo JM, Young G, Schantz SP. Clayman GL, et al. Among authors: taylor dl. Arch Otolaryngol Head Neck Surg. 1992 Jan;118(1):41-8. doi: 10.1001/archotol.1992.01880010045014. Arch Otolaryngol Head Neck Surg. 1992. PMID: 1370199

8

Detection of regulatory factors of lymphokine-activated killer cell activity in head and neck cancer patients treated with interleukin-2 and interferon alpha.

Clayman GL, Young G, Taylor DL, Savage HE, Lavedan P, Schantz SP. Clayman GL, et al. Among authors: taylor dl. Ann Otol Rhinol Laryngol. 1992 Nov;101(11):909-15. doi: 10.1177/000348949210101105. Ann Otol Rhinol Laryngol. 1992. PMID: 1444098 Clinical Trial.

9

Immunomodulation of the induction phase of lymphokine-activated killer activity by acute phase proteins.

Clayman GL, Liu FJ, Taylor DL, Savage HE, Lavedan P, Buchsbaum RM, Trujillo JM, Schantz SP. Clayman GL, et al. Among authors: taylor dl. Otolaryngol Head Neck Surg. 1991 Jul;105(1):26-34. doi: 10.1177/019459989110500104. Otolaryngol Head Neck Surg. 1991. PMID: 1715542

10

Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cells.

Clayman GL, Taylor DL, Liu FJ, Lavedan P, Savage HE, Schantz SP. Clayman GL, et al. Among authors: taylor dl. Laryngoscope. 1993 Mar;103(3):299-307. doi: 10.1288/00005537-199303000-00010. Laryngoscope. 1993. PMID: 7680086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

493 results

Search Page

Filters